Analysed THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) News Sources
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
13-04-2026
yahoo.com
Theralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
17-03-2026
yahoo.com
Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer
09-03-2026
yahoo.com
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
20-02-2026
yahoo.com
Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
17-02-2026
yahoo.com
Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
10-02-2026
yahoo.com
What is the current price of THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)?
The current price of THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) is $0.2075.
THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) since the previous trading day is $0.0225.
THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) since the previous trading day is 12.1622%.
What is the most recent average sentiment score for THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)?
The most recent average sentiment score for THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) is 83 out of 100.
What is the most recent average sentiment for THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)?
The most recent sentiment for THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS) is .
SEC-8K** Filing Available For THERALASE TECHNOLOGIES INC (TLTFF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.